New UA/Banner Health Valley Fever Clinical Guidelines to Help Avoid Delays in Diagnosis
Banner Health has launched new clinical practice protocols developed with input from the University of Arizona Valley Fever Center for Excellence to help physicians more quickly diagnose and treat patients with Valley fever infections.
A research team led by Jared Churko, PhD, director of the University of Arizona iPSC Core in the UA Sarver Heart Center, used a transcriptomic approach – studying what genes are expressed – to identify gene signatures of cell subpopulations identified as atrial-like or ventricular-like. This understanding could lead to regenerative therapy discoveries for the millions of people living with damaged heart muscle caused by heart attacks or other chronic heart conditions.
Michael Kruer, MD, receives the first federally funded grant to research genetic causes of condition that affects 1 in 250 children.
Resistant strains of bacteria pose a serious threat to the security of our global health system. As more and more bacteria develop resistance to our best antibiotics, once treatable diseases may re-emerge, potentially causing mass epidemics.
Individuals with a particular genetic factor may be more resistant to plaque build-up and have a reduced risk for coronary artery disease.
In a new study, Stephen Albert Johnston and his colleagues describe a method for pinpointing tumor-specific factors in blood that can elicit a protective immune response in the body and may one day be harnessed to produce an effective vaccine against the disease.
It’s time to start planning for J P Morgan Healthcare Week
AZBio Members have the opportunity to lock in a significant discount on two premier registration packages for the 2019 BIO International Convention in Philadelphia, June 3-6: Convention Access and Convention Access & Partnering.
Save the date: AZBio Government Affairs Call: 
